<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335023">
  <stage>Registered</stage>
  <submitdate>15/01/2010</submitdate>
  <approvaldate>18/01/2010</approvaldate>
  <actrnumber>ACTRN12610000050055</actrnumber>
  <trial_identification>
    <studytitle>laser correction of far sightness using different  laser parameters</studytitle>
    <scientifictitle>Correlation of refractive outcomes with increasing optical zone diameter in hyperopic Lasik in patients with bilateral hyperopia</scientifictitle>
    <utrn>U1111-1113-3327</utrn>
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hyper metropia</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Hyperopic lasik correction for hyperopia more than +4 diopters using 2 optical zones diameter ,6 mm and 6.5 mm. we compare the 6.5 mm to the standdred 6.00 mm regarding efficacy,stability and saftey. this is a one off intervention and each patient is his own controll</interventions>
    <comparator>The comparator is the fellow eye of the same patient receiving  6.0 mm optical zone diameter.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Patients refraction in diopters as a measure of predictability of the treatment (1 ry outcome). This is measured by objective cycloplegic refraction by retinoscopy a and verified by subjective refraction and measurement of visual acuity using the snellens chart</outcome>
      <timepoint>one week post treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patients refraction in diopters after 6 months as a measure of stability of the treatment (2ry outcome.This is measured by objective cycloplegic refraction by retinoscopy a and verified by subjective refraction and measurement of visual acuity using the snellens chart</outcome>
      <timepoint>6 months post treatment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Bilateral hyperopia &gt; 4 diopters.</inclusivecriteria>
    <inclusiveminage>29</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Amblyopia
central keratometry &gt;45 diopters
central pcchymetry &lt; 500 microns
associated ocular disease as glaucoma , cataract corneal dystrophies and retinal diseases</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>patients were assigned to do a bilateral hyper opic lasik.
The rigth eyes of all patients had a 6 mm diameter optical zone treatment. while left eyes recieved a 6.5 mm optical zone diameter treatment</concealment>
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/05/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Mostaf A EL-Helw</primarysponsorname>
    <primarysponsoraddress>52 Manyal street, Manyal 11451
Cairo, Egypt</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Mostaf A EL-Helw</fundingname>
      <fundingaddress>52 Manyal street, Manyal 11451
Cairo, Egypt</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Al-Nour eye Hospital</sponsorname>
      <sponsoraddress>93 Mostafa El Nahas street. Nasr city,
Cairo, Egypt</sponsoraddress>
      <sponsorcountry>Egypt</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>results of Lasik correction of moderate hyperopia was allways challanged as far as accuracy of the correction and its stability of the achieved results. It is hypothesised that increasing the diameter of the optical zone will increase the accuracy and stability of the outcome.In this study 2 different optical zone diameter were used in the same patient. In which one eye recieved a 6 mm and the other eye recieved a 6.5 mm diameter optical zone. and the outcomes were compared between both eyes.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Al-Nour eye hospital ethical committe</ethicname>
      <ethicaddress>93 mostafa El-Nahas street, Nasr city.
Cairo, Egypt</ethicaddress>
      <ethicapprovaldate>15/04/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mostafa Aly EL-Helw</name>
      <address>52 manyal street, manyal 11451
Cairo, Egypt</address>
      <phone>+20101228920</phone>
      <fax />
      <email>helw@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mostafa Aly EL-Helw</name>
      <address>52 manyal street, manyal 11451
Cairo, Egypt</address>
      <phone>+20101228920</phone>
      <fax />
      <email>helw@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mostafa Aly EL-Helw</name>
      <address>52 manyal street, manyal 11451
Cairo, Egypt</address>
      <phone>+20101228920</phone>
      <fax />
      <email>helw@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>